US 9498544
Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
granted A61KA61K2035/124A61K2039/505
Quick answer
US patent 9498544 (Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents) held by Tissue Regeneration Therapeutics Inc. expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tissue Regeneration Therapeutics Inc.
- Grant date
- Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2035/124, A61K2039/505, A61K2239/31, A61K35/44